SUBSCRIBE
SUBSCRIBE

Pharm Country

Connecticut, New York, New Jersey, Pennsylvania and Rhode Island

The northeast region of Pharm Country typically attracts a good deal of venture capital dollars, particularly as onlookers seek direction from Wall Street.

Major research universities, including University of Pennsylvania, Penn State University, Carnegie Mellon, Rutgers and Ivy Leagues Princeton, Yale, Cornell and Columbia contribute to this concentration of biopharma excellence.

Pharm Country is home to several state life sciences associations including BioCT, NewYorkBIO, BioNJ, Life Sciences PA and RI Bio.

NEWS FROM PHARM COUNTRY
Boy sitting in a wheelchair
Friedreich’s ataxia
Lexeo’s Gene Therapy Shows Early Promise for Friedreich’s Ataxia Cardiomyopathy
July 15, 2024
 · 
2 min read
 · 
Tristan Manalac
3D illustration of a T cell killing a cancer cell
CAR-T
Interius Gets Go-Ahead for Phase I Trial of In Vivo CAR-T Therapy in Australia
July 10, 2024
 · 
2 min read
 · 
Tristan Manalac
External view of Boehringer Ingelheim's headquarters in Silicon Valley
Legal
Boehringer Ingelheim Loses Legal Challenge to IRA in Connecticut Federal Court Ruling
July 8, 2024
 · 
2 min read
 · 
Tristan Manalac
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
FEATURED COMPANIES
See the latest job opportunities in Pharm Country
SEARCH JOBS
Merck Research Laboratories headquarters in Silicon Valley
Mergers & acquisitions
Merck Puts Up Potential $1.3B to Acquire Curon’s B Cell Depletion Therapy
Merck is paying $700 million upfront to buy Curon Biopharmaceutical’s bispecific antibody which depletes B cells and is being investigated for non-Hodgkin’s lymphoma and B cell acute lymphocytic leukemia.
August 9, 2024
 · 
2 min read
 · 
Tristan Manalac
FDA sign in front of its building in Maryland
Approvals
Citius Scores FDA Approval in Cutaneous T Cell Lymphoma
August 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Merck Research Laboratories in South San Francisco, California
Lung Cancer
Merck Halts Phase III Trial of Keytruda, Anti-TIGIT Combo in Small Cell Lung Cancer
August 8, 2024
 · 
2 min read
 · 
Tyler Patchen
MORE COMPANIES IN PHARM COUNTRY
Arvinas Inc.
CSL
Daiichi Sankyo
Drexel University
Exelixis, Inc.
GenScript
Novo Nordisk
Pictured: Injection pens meant for weight-loss medications
Business
Weight-Loss Drug Startup Metsera Launches with $290M, Looks to Tap Lucrative Obesity Market
April 18, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Regeneron logo on a light brown building
Pharm Country
Regeneron Launches $500M Venture Capital Fund Skewed Toward Biotech
April 15, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Exterior of the FDA headquarters in Mary
Drug Development
FDA Rejects Regeneron’s Blood Cancer Therapy for Two Forms of Lymphoma
March 25, 2024
 · 
2 min read
 · 
Tyler Patchen
Pictured: Pfizer's signage at its world headquarters in New York
Pharm Country
Pfizer to Lower Its Stake in GSK Consumer Health Spinoff Haleon
March 18, 2024
 · 
1 min read
 · 
Tyler Patchen
Load More
MORE COMPANIES IN PHARM COUNTRY
Azitra, Inc.
Bolden Therapeutics
Cybrexa Therapeutics
Focus Laboratories
Formation Bio
Idorsia Pharmaceuticals
Insmed Incorporated
Intra-Cellular Therapies, Inc
Johnson & Johnson Family of Companies
Ocugen, Inc.
OrphAI Therapeutics
Protara Therapeutics
Resilience
Sapience Therapeutics, Inc.
SELLAS Life Sciences Group
(PRNewsfoto/Soligenix, Inc.)
Soligenix
Tris Pharma
Volastra Therapeutics
Interested in appearing on the Hotbed Maps?
Find out how your organization can be featured!
LEARN MORE